One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A systematic review of patient-derived tumor organoids generation from malignant effusions
Sofie Seghers a,b,*,1, Maxim Le Compte b, Jeroen M.H. Hendriks c,d,h, Paul Van Schil d,h, Annelies Janssens e, Reinier Wener e,f, Niels Komen g,h, Hans Prenen a,b,c, Christophe Deben
doi : 10.1016/j.critrevonc.2024.104285
Volume 195, March 2024, 104285
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
Rafael Rosell a,b,*, Jordi Codony-Servat c, Jessica Gonz´alez a, Mariacarmela Santarpia d, Anisha Jain e, Chandan Shivamallu f, Yu Wang g, Ana Gim´enez-Capit´an c, Miguel A. Molina-Vila c, Jonas Nilsson h, Mar?a Gonz´alez-Cao
doi : 10.1016/j.critrevonc.2023.104228
Volume 195, March 2024, 104228
Progression of radio-labeled molecular imaging probes targeting chemokine receptors
Heqing Yi a,b,1, Lilin Qin c,1, Xuemei Ye a, Jinling Song a, Jianfeng Ji a, Ting Ye a, Juan Li d,*, Linfa Li
doi : 10.1016/j.critrevonc.2024.104266
Volume 195, March 2024, 104266
Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
Fang Cheng a,b, Hongxiang Wang c, Weiming Li d,*, Yu Zhang
doi : 10.1016/j.critrevonc.2024.104258
Volume 195, March 2024, 104258
Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment
Ilaria Tortorelli a,b, Elena Bellan c, Benedetta Chiusole a, Fabio Murtas a,b, Pietro Ruggieri d, Elisa Pala d, Mariachiara Cerchiaro d, Maria Samaritana Buzzaccarini e, Giovanni Scarzello e, Marco Krengli e, Gianluca Bisinella f, Sara Battisti f, Antonio Di Maggio g, Vittorina Zagonel a, Angelo Paolo Dei Tos c,h, Marta Sbaraglia c,h, Antonella Brunello
doi : 10.1016/j.critrevonc.2024.104268
Volume 195, March 2024, 104268
Why does HER2-positive breast cancer metastasize to the brain and what can we do about it?
Dongyan Xu a,b,1, Zhengfang Hu c,1, Kaiyue Wang a,b, Shiyao Hu a,b, Yunxiang Zhou a,b, Shizhen Zhang a,b, Yiding Chen a,b, Tao Pan a,b
doi : 10.1016/j.critrevonc.2024.104269
Volume 195, March 2024, 104269
RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities
Shimeng Wang a,1, Hexing Sun a,1, Guanyuan Chen a,1, Chengyu Wu a, Bingmei Sun a, Jiajia Lin a, Danping Lin b, De Zeng b, Baohang Lin c, Guan Huang d, Xiaofeng Lu a, Haoyu Lin a,*, Yuanke Liang
doi : 10.1016/j.critrevonc.2024.104271
Volume 195, March 2024, 104271
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
Stefano Natangelo a,b,c, Dario Trapani a,b, Chrysanthi Koukoutzeli a, Luca Boscolo Bielo a,b, Giulia Marvaso d, Barbara Alicja Jereczek-Fossa b,d, Giuseppe Curigliano
doi : 10.1016/j.critrevonc.2024.104270
Volume 195, March 2024, 104270
Lung toxicity induced by anti-HER2 antibody – drug conjugates for breast cancer
doi : 10.1016/j.critrevonc.2024.104274
Volume 195, March 2024, 104274
Clinical decision support systems for multidisciplinary team decision-making in patients with solid cancer: Composition of an implementation model based on a scoping review☆
Mathijs P. Hendriks a,b,c,*,1, Agnes Jager d, Kees C.W.J. Ebben b, Janine A. van Til a, Sabine Siesling
doi : 10.1016/j.critrevonc.2024.104267
Volume 195, March 2024, 104267
Feasibility metrics of exercise interventions during chemotherapy: A systematic review
Neil Kearney a,b,*, Deirdre Connolly b,c, Sanela Begic b,d, David Mockler e, Emer Guinan
doi : 10.1016/j.critrevonc.2024.104272
Volume 195, March 2024, 104272
